© 2025 American City Business Journals. All rights reserved. Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement ...

Five months after giving up on its lead drug Betalutin for follicular lymphoma, Nordic Nanovector has charted a course forward via a merger with fellow Norwegian biotech APIM Therapeutics.

A Kellogg MBA is your gateway to a global community, countless personal and professional opportunities and access to the sharpest minds in business.

Sign Up for Wine Spectator’s Free Email Newsletters and stay up-to-date with all things wine.